This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Injectable Drug Delivery To 2018 - Drugs, Devices, Targets, Therapeutics And Forecasts

NEW YORK, Feb. 25, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Injectable Drug Delivery to 2018 - Drugs, Devices, Targets, Therapeutics and Forecasts http://www.reportlinker.com/p01109064/Injectable-Drug-Delivery-to-2018---Drugs-Devices-Targets-Therapeutics-and-Forecasts.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. This report examines the key therapeutic, product, market and regulatory factors for injectable drugs across ten major disease and therapeutic classes, providing essential insight and forecasts into the implications of this evolving landscape.

Highlights• Analyzes and evaluates the shifting landscape for injectable drug delivery and assesses the market impact of new and emerging injectable drug products by therapeutic indication• Analyzes syringe and injector device designs, feature/functionality, product branding, competing technologies and market development issues• Provides detailed descriptions of key injectable drug therapeutic market segments, market demographics, and business strategies• Forecasts Injectable drug product demand by indication and therapy to 2018• Profiles leading injection device companies, their product development activities, business strategies, and corporate alliances and affiliations

Summary of ContentsExecutive SummaryInjectable Drug Delivery Market DynamicsThe Injectable Drug EcosystemInjectable Drug Demand DriversDrug Development FactorsMarket FactorsTechnology FactorsCompetitive LandscapeAutoinjectorsNeedle-free InjectorsPen InjectorsPrefilled SyringesSafety Syringes Injectable Drug Demand DriversDiseases and IndicationsPatient DemographicsDeveloping Economies Risks and OpportunitiesInjectable Drug Device Selection CriteriaStability and Material Selection IssuesSingle vs Multi-Dose DevicesLyophilized Drugs/ReconstitutionSyringe Safety/Sharps ProtectionNeedle Configuration StrategiesDisposable Drug CartridgesHuman Engineering/ErgonomicsBranding/Private LabelingInjectable Drug Delivery – Device SegmentsAutoinjectorsAutoinjector-specific Selection FactorsPart Counts and Device Cost Safety Features Needle Shielding Needle Insertion Depth Failsafe Activation Dose Inspection/Injection ConfirmationAutoinjector Device Categories Reusable Autoinjectors Disposable Autoinjectors Product Specific Autoinjectors Drugs and Therapeutic SegmentsNeedle-free InjectorsDevice CategoriesEnd User/Practitioner/Mass Immunization InjectorsPrefilled Disposable ModelsRefillable Cartridge DesignsNeedle-free Injector-specific Selection FactorsEnergy SourceInjection Site SelectionPen InjectorsPen Injector Device CategoriesStandardized Pen PlatformsCustom Pen DesignsReusable PensPrefilled Pen CartridgesDisposable PensDual Chamber PensBranded Drug/Pen Injector Product by Therapeutic Segment Prefilled SyringesPrefilled Syringe Device CategoriesGlass Prefilled SyringesPrefillable Glass Syringe Manufacturers and Branded DevicesBranded Drug/Prefilled Glass Syringe Products by Therapeutic SegmentPlastic Prefilled SyringesBranded Prefillable Plastic SyringesDrugs and Therapeutic SegmentsPrefillable Safety SyringesPrefilled Syringe-specific Selection FactorsPFS Manufacturing FactorsFill-and-Finish OperationsSafety SyringesSafety Syringe Device CategoriesPrefillable Integrated Safety SyringesNon-Prefillable Integrated Safety SyringesRetractable NeedleManually RetractableAutomatic RetractableSliding SheathInjectable Drug Delivery – Therapeutic Segment Analysis & ForecastsAnaphylaxisAnticoagulantsAntiviralsAutoimmune DiseasesEmergency MedicineHematopoieticsHormone ReplacementMetabolic DiseasesNeurologyReproductive HealthVaccinesInjectable Drug Therapeutics - Market Factors Regulatory Factors and IssuesFDA RegulationsRegulating Combination Products Sharps LegislationsGrowth and Diversity of Safety SyringesSharps DisposalClinical Trial FactorsManaged Care and Healthcare Economics Company Profiles

To order this report: Drug_Delivery_Technology Industry: Injectable Drug Delivery to 2018 - Drugs, Devices, Targets, Therapeutics and Forecasts

__________________________Contact Clare: clare@reportlinker.comUS:(339) 368 6001Intl:+1 339 368 6001

 

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,814.94 -2.96 -0.02%
S&P 500 2,067.03 -2.38 -0.12%
NASDAQ 4,758.2520 +3.36 0.07%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs